Home
Latest Filings
Latest Buys
Latest Sells
Institutions
Derivatives
Hot Buys
Data Screener
Email Alerts
Insider Charts
RVNC
- As of 05/21/24, 05:22:13 AM: 19 Insider Transactions.
Sector:
Healthcare
Industry:
Biotechnology
Prev Close:
$13.25
Avg Vol(3m):
303,200
P/E:
0.00
EPS:
-3.07
Email this page to a friend.
Insider Transactions for RVNC
Buy/Sell*
Filed Date
Subject
Symbol
Acquirer
Pct Owned
Details
S
2020-08-10 09:43:11.0
Revance Therapeutics
RVNC
BlackRock Inc
7.2%
view
S
2020-01-17 10:33:17.0
Revance Therapeutics
RVNC
JPMORGAN CHASE & CO
11.44%
view
S
2019-11-12 11:27:57.0
Revance Therapeutics
RVNC
ArrowMark Colorado Holdings LLC
4.81%
view
S
2019-02-14 07:53:43.0
Revance Therapeutics
RVNC
ArrowMark Colorado Holdings LLC
9.04%
view
B
2019-02-12 11:36:23.0
Revance Therapeutics
RVNC
WELLINGTON MANAGEMENT GROUP LLP
11.66%
view
B
2019-02-06 17:28:18.0
Revance Therapeutics
RVNC
Bank of New York Mellon Corp
6.89%
view
B
2019-01-28 15:40:35.0
Revance Therapeutics
RVNC
JPMORGAN CHASE & CO
10.2%
view
S
2018-04-10 11:03:12.0
Revance Therapeutics
RVNC
Essex Woodlands Health Ventures VIII
10.52%
view
B
2018-02-09 09:37:06.0
Revance Therapeutics
RVNC
WELLINGTON MANAGEMENT GROUP LLP
9.84%
view
S
2018-02-07 15:10:34.0
Revance Therapeutics
RVNC
Bank of New York Mellon Corp
5.9%
view
B
2018-01-25 14:09:56.0
Revance Therapeutics
RVNC
BlackRock Inc
7.1%
view
S
2017-02-09 13:19:19.0
Revance Therapeutics
RVNC
FRANKLIN RESOURCES INC
10.9%
view
B
2017-02-03 12:50:47.0
Revance Therapeutics
RVNC
Bank of New York Mellon Corp
7.1%
view
B
2017-01-11 12:49:32.0
Revance Therapeutics
RVNC
Essex Woodlands Health Ventures VIII
16.4%
view
S
2016-02-10 13:40:28.0
Revance Therapeutics
RVNC
NovaQuest Pharma Opportunities Fund III
11.1%
view
B
2016-01-28 15:59:50.0
Revance Therapeutics
RVNC
Bank of New York Mellon Corp
7.16%
view
B
2016-01-21 16:54:02.0
Revance Therapeutics
RVNC
JPMORGAN CHASE & CO
10.4%
view
S
2015-02-17 07:53:29.0
Revance Therapeutics
RVNC
Visium Asset Management
4.2%
view
B
2015-01-09 13:09:19.0
Revance Therapeutics
n/a
Visium Asset Management
6.1%
view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.